Skip to main content

Day: November 22, 2024

Nokia launches share buyback program to offset the dilutive effect of the Infinera acquisition

Nokia CorporationStock Exchange Release22 November 2024 at 12:15 EET Nokia launches share buyback program to offset the dilutive effect of the Infinera acquisition Espoo, Finland – In line with the announcement made on 27 June 2024, Nokia Corporation (“Nokia” or the “Company”) has today decided to launch a share buyback program to offset the dilutive effect of issuing new shares to the shareholders of Infinera Corporation and from Infinera’s existing share-based incentives. The daily buyback volume is expected to increase following the completion of the Infinera acquisition, and the program will be terminated if the acquisition is cancelled. The main terms of the share buyback program: •      The program targets to repurchase 150 million shares, for an aggregate purchase price not exceeding EUR 900 million. •      The...

Continue reading

Leading International Law Firms to Host Webinar on November 28, 2024 at 2:30PM AEDT on Going Public in the US for APAC Companies

PERTH, Nov. 22, 2024 (GLOBE NEWSWIRE) — Globavend Holdings Limited (Nasdaq: GVH) (“Globavend”), an emerging e-commerce logistics services provider, today announced that it will present in a live webinar teamed up by international law firms on Going Public in the US – an APAC Experience. The webinar will be held on November 28, 2024, at 2:30 p.m. AEDT. Participants will gain insights from the Nasdaq and industry experts in going public in the US. At the webinar, Neil Waldron, Nasdaq’s Director of Corporate Platforms, and Frank Yau, Chairman and CEO of Globavend, alongside leading international law firms, including K&L Gates LLP and Conyers Dill & Pearman, and industry experts will share the benefits and strategies of going public in the US, their knowledge and experience in bringing businesses public in the US, with particular...

Continue reading

Behavioral Rehabilitation Market to Witness 6.9% CAGR by 2031 | SkyQuest Technology

Several factors have allowed for such growth including increased understanding of behavioral health through advancements in psychology and improved public awareness about mental disorders. Westford, USA, Nov. 22, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that Behavioral Rehabilitation Market Size will attain the value of USD 646.44 Billion by 2031, with a CAGR of 6.9% during the forecast period (2024-2031). The behavioral rehabilitation industry is expected to grow rapidly in the coming years. Behavioral problems are expected to increase, and consequently this will drive growth in the behavioral rehabilitation market. Behavioral disorders are a group of illness characterized by negative emotions as well as actions that significantly impair an individual’s ability to perform normally every day and enjoy existence.  Browse in-depth...

Continue reading

Agricultural Biotechnology Market to Evolve at an Impressive 8.8% CAGR through 2031 | SkyQuest Technology

Rapidly increasing global population is forecasted to augment the demand for agricultural biotechnology over the coming years. Westford, USA, Nov. 22, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the agricultural biotechnology market size will attain a value of USD 227.77 billion by 2031, with a CAGR of 8.8% over the forecast period (2024-2031). Rapidly increasing global demand for food owing to the rising global population and emphasis on improving agricultural yield are slated to bolster agricultural biotechnology market growth over the coming years. Bio-based agricultural biotechnology products are estimated to be highly sought-after in the long run.   Browse in-depth TOC on “Agricultural Biotechnology Market”  Pages – 168  Tables – 97  Figures – 68To Learn More About This Report, Request a Free...

Continue reading

Rosacea Treatment Market to Surpass Valuation of USD 3.16 Billion by 2031 | SkyQuest Technology

Rising incidence of skin disorders and growing awareness regarding skin care among people around the world are key factors promoting the demand for rosacea treatment. Westford, USA, Nov. 22, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the global rosacea treatment market size will reach a value of USD 3.16 Billion by 2031, with a CAGR of 6.5% during the forecast period (2024-2031). High illness prevalence, sophisticated formulations, and proactive government activities are some of the factors driving market expansion. Despite affecting over 400 million individuals globally, rosacea is still not well understood. An estimated 5% of people worldwide are affected by the condition. Fair-skinned people, particularly women, are more likely to have this disorder. Due to a number of similarities in presentation, the condition is frequently...

Continue reading

Sunlands Technology Group Announces Unaudited Third Quarter 2024 Financial Results

BEIJING, Nov. 22, 2024 (GLOBE NEWSWIRE) — Sunlands Technology Group (NYSE: STG) (“Sunlands” or the “Company”), a leader in China’s adult online education market and China’s adult personal interest learning market, today announced its unaudited financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial and Operational SnapshotsNet revenues were RMB491.3 million (US$70.0 million), compared to RMB524.6 million in the third quarter of 2023. Gross billings (non-GAAP) were RMB360.3 million (US$51.3 million), compared to RMB390.0 million in the third quarter of 2023. Gross profit was RMB409.2 million (US$58.3 million), compared to RMB460.5 million in the third quarter of 2023. Net income was RMB89.3 million (US$12.7 million), compared to RMB131.6 million in the third quarter of 2023. Net income margin1...

Continue reading

Succession in Jyske Realkredit

22nd November 2024Announcement no. 95/2024To NASDAQ Copenhagen A/S                                                                Succession in Jyske Realkredit After 34 years with Jyske Realkredit (former BRFkredit), Carsten Tirsbæk Madsen plans to retire. He will retire in the second quarter of 2025. Carsten Tirsbæk Madsen started his career at BRFkredit in 1990. He was in 2001 appointed a member of the Executive Board and CEO of Jyske Realkredit in 2014. He has been chairman of the Association of Danish Mortgage Banks (2020-2024) and of the interest organisations of the mortgage credit industry in Bruxelles, European Mortgage Federation (2018-2020) and European Covered Bond Council (2015-2017). Anders Lund Hansen will be appointed as new CEO in the second quarter of 2025. Anders Lund Hansen has been with Jyske Realkredit for 16 years...

Continue reading

Succession in Jyske Realkredit

After 34 years with Jyske Realkredit (former BRFkredit), Carsten Tirsbæk Madsen plans to retire. He will retire in the second quarter of 2025. Carsten Tirsbæk Madsen started his career at BRFkredit in 1990. He was in 2001 appointed a member of the Executive Board and CEO of Jyske Realkredit in 2014. He has been chairman of the Association of Danish Mortgage Banks (2020-2024) and of the interest organisations of the mortgage credit industry in Bruxelles, European Mortgage Federation (2018-2020) and European Covered Bond Council (2015-2017). Anders Lund Hansen will be appointed as new CEO in the second quarter of 2025. Anders Lund Hansen has been with Jyske Realkredit for 16 years and has since June 2023 been a member of the Executive Board. He has broad experience with balance management at Jyske Realkredit and has previously held a wide...

Continue reading

Gene Panel Market to Surpass USD 11.75 Billion by 2031 | SkyQuest Technology

Gene panels are now more reasonably priced due to the decline in the cost of genomic sequencing, which makes comprehensive genetic testing and analysis of a broad variety of illnesses possible. Westford, USA, Nov. 22, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Global Gene Panel Market share will reach a value of USD 11.75 Billion by 2031, with a CAGR of 19.30% during the forecast period (2024-2031). The gene panel industry is growing due to the increased requirement for genetic screening to prevent the death rates from genetic abnormalities and the growing incidence of cancer and hereditary disorders. Furthermore, the main strategy used by physicians to improve illness prediction and therapy is determining the genetic propensity for different forms of cancer or other genetic problems. Globally, there were almost 20 million...

Continue reading

Sampo plc’s share buybacks 21 November 2024

Sampo plc, stock exchange release, 22 November 2024 at 8:30 am EET Sampo plc’s share buybacks 21 November 2024 On 21 November 2024, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  4,621 39.71 AQEU          43,642 39.69 CEUX  359 39.68 TQEX  46,236 39.70 XHELTOTAL 94,858 39.69  *rounded to two decimals                 On 17 June 2024, Sampo announced a share buyback programme of up to a maximum of EUR 400 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. On 16 September 2024, the Board of Directors...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.